These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17498291)

  • 21. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.
    Wolf JS; Chen Z; Dong G; Sunwoo JB; Bancroft CC; Capo DE; Yeh NT; Mukaida N; Van Waes C
    Clin Cancer Res; 2001 Jun; 7(6):1812-20. PubMed ID: 11410524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
    Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I
    Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
    Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
    Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.
    Duffey DC; Crowl-Bancroft CV; Chen Z; Ondrey FG; Nejad-Sattari M; Dong G; Van Waes C
    Br J Cancer; 2000 Nov; 83(10):1367-74. PubMed ID: 11044363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.
    Macha MA; Matta A; Chauhan SS; Siu KW; Ralhan R
    Carcinogenesis; 2011 Mar; 32(3):368-80. PubMed ID: 21177768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.
    Aggarwal S; Takada Y; Singh S; Myers JN; Aggarwal BB
    Int J Cancer; 2004 Sep; 111(5):679-92. PubMed ID: 15252836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.
    Allen C; Saigal K; Nottingham L; Arun P; Chen Z; Van Waes C
    Clin Cancer Res; 2008 Jul; 14(13):4175-85. PubMed ID: 18593997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
    Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
    Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation.
    Szołtysek K; Janus P; Zając G; Stokowy T; Walaszczyk A; Widłak W; Wojtaś B; Gielniewski B; Cockell S; Perkins ND; Kimmel M; Widlak P
    BMC Genomics; 2018 Nov; 19(1):813. PubMed ID: 30419821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
    Lin Y; Mallen-St Clair J; Luo J; Sharma S; Dubinett S; St John M
    Oral Oncol; 2015 Oct; 51(10):921-8. PubMed ID: 26306422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear factor-KappaB as a common target and activator of oncogenes in head and neck squamous cell carcinoma.
    Chang AA; Van Waes C
    Adv Otorhinolaryngol; 2005; 62():92-102. PubMed ID: 15608421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck.
    Yeudall WA; Jakus J; Ensley JF; Robbins KC
    Mol Carcinog; 1997 Feb; 18(2):89-96. PubMed ID: 9049184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma.
    Chen Z; Zhang K; Zhang X; Yuan XH; Yuan Z; Jin L; Xiong M
    Clin Exp Metastasis; 2003; 20(4):335-42. PubMed ID: 12856721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.